Conditions: Essential Hypertension
Keywords: essential hypertension
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 115
Healthy volunteers: no

Brief summary:
The population that will be included in this study, will be regular Turkish hypertensive patients who are expected to consume sodium in high amounts. It is hypothesized that, in that population, amlodipine/valsartan will be effective at the same rate of blood pressure (BP) control rate as expected from literature.

Detailed description:

Arms:
arm 1: All patients will receive amlodipine/valsartan 5/160 mg daily in screening and up titrated to amlodipine/valsartan 10/160 mg daily at visit 2 (day 30) if their hypertension can not be controlled. The duration of treatment period is 8 weeks.

Interventions: intervention 1: amlodipine/valsartan
Intervention descriptions: intervention 1: Fixed combination of amlodipine and valsartan in tablet; 5/160/mg, 10/160 mg

Protocol document: